INFOGRAPHIC: Navigating Treatments After ET + CDK4/6is and ET Limitations in ER+ HER2- ABC
This infographic summarizes the complex treatment landscape after progression or recurrence on ET+ CKD4/6 inhibitors in ER+, HER2-, ABC and the limitations for the 3 main classes of approved ETs
Date of Last Review: March 28, 2024
Are you satisfied with this content?